top of page

ABOUT THE APPIS INNOVATOR PROGRAM

Launched in 2022, the APPIS Innovator Program recognizes and supports patient organizations in APMA that have excelled in improving patient access to the right information, treatment, and care.

 

Every year, our esteemed expert panel of judges select winners based on submissions, with each submission undergoing a rigorous evaluation process based on five key criteria: impact, innovation, potential to scale, fit to category, and progression. Shortlisted contestants will then be invited to participate to a closed door pitch to present their initiatives where the winners will be selected. 
 

The program partners with the winning patient organizations to help scale their innovative patient solutions to bring them closer to achieving their mission of helping more patients have better access to healthcare. 

WHY APPLY?

APPIS network and partnership with strategic stakeholders

Layer 2.png

To be channeled back to the initiative to create even bigger impact

Promotion of the initiative through APPIS platform and on-going engagement

Consistent coaching/membership and guidance from thought leaders within the patient community

Network

Visibility

Financial Support

Coaching

Qualifying Criteria for Patient Organizations

appis-innovator-program-removebg-preview.png
  • Any patient organization that is officially registered and demonstrating impact within Asia Pacific, Middle East, and Africa.

  • The organization must have an initiative that is on-going, or "live" at the time of submission.

  • The organization will have proven outcome or impact within their intended patient community, within the last 2 years.

  • Must be able to accurately represent the work done and impact achieved. 

appis-innovator-program-3.jpg
appis-innovator-program-4.jpg

Health Literacy

Innovative and impactful initiatives that have significantly driven disease awareness and scientific/medical knowledge sharing. 

appis-innovator-program-5.jpg

Health Policy Shaping

Programs or methodologies that have enabled or accelerated access to healthcare, information, prevention, treatment or care, through partnerships between patients and policy makers.

JUDGING CRITERIA

appis-innovator-program-6.jpg

Impact

  • What value has the initiative brought to patients?

  • How has it solved problems for patients?

appis-innovator-program-7.jpg

Innovation

  • Is it original and innovative?

  • Does it take a future-ready approach, and apply disruptive digital and/or comms tools and technologies? 

appis-innovator-program-8.jpg

Potential to Scale

  • Is it a one-off initiative or one that can scale and grow?

  • Is it a replicable model that can be adapted by other countries and/or disease areas? 

appis-innovator-program-9.jpg

Fit to Category

  • Does it address current gaps in Health Literacy or aid in Health Policy Shaping, in the key disease areas of interest:
    - Cardiovascular disease
    - Oncology
    - Neuromuscular disease
    - Immunological disease 

appis-innovator-program-10.jpg

Progression

  • Does the initiative show growth or improvement from the time of inception?

  • How can the support from the Innovator program help it further scale the initiative and increase impact?

Click here for details on APPIS Innovator Program 2024

bottom of page